Literature DB >> 8392487

The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.

M E Trautmann1, C Neuhaus, H Lenze, R Benning, M Benning, H J Dennler, C Bruns, K Joseph, R Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8392487

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN： 0170-5903


× No keyword cloud information.
  4 in total

1.  Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.

Authors:  P Ruszniewski; M Ducreux; J A Chayvialle; J Blumberg; D Cloarec; H Michel; J M Raymond; J L Dupas; H Gouerou; R Jian; E Genestin; P Bernades; P Rougier
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

2.  Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.

Authors:  M Nocaudie-Calzada; D Huglo; B Carnaille; C Proye; X Marchandise
Journal:  Eur J Nucl Med       Date:  1996-11

Review 3.  Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1994-06

Review 4.  Systemic treatment for lung carcinoids: from bench to bedside.

Authors:  Mariangela Torniai; Laura Scortichini; Francesca Tronconi; Corrado Rubini; Francesca Morgese; Silvia Rinaldi; Paola Mazzanti; Rossana Berardi
Journal:  Clin Transl Med       Date:  2019-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.